Literature DB >> 18077924

The association of interferon with the development of pulmonary tuberculosis.

R Farah1, J Awad.   

Abstract

We report a new case of a patient suffering from chronic hepatitis C (CHC) and treated with interferon-alpha2a (IFN-alpha) who presented with the diagnosis of active pulmonary tuberculosis. Interferon was stopped and appropriate treatment with antituberculous drugs initiated. Several weeks later the patient was free of clinical symptoms. Our case demonstrates a rare association between interferon and tuberculosis since only one case in the literature has described a similar association.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18077924     DOI: 10.5414/cpp45598

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther        ISSN: 0946-1965            Impact factor:   1.366


  6 in total

Review 1.  Antitubercular therapy in patients with cirrhosis: challenges and options.

Authors:  Naveen Kumar; Chandan Kumar Kedarisetty; Sachin Kumar; Vikas Khillan; Shiv Kumar Sarin
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

2.  Tuberculosis screening before anti-hepatitis C virus therapy in prisons.

Authors:  Sergio Babudieri; Andrea Soddu; Monica Murino; Paola Molicotti; Alberto A Muredda; Giordano Madeddu; Alessandro G Fois; Stefania Zanetti; Pietro Pirina; Maria Stella Mura
Journal:  Emerg Infect Dis       Date:  2012-04       Impact factor: 6.883

3.  Incidence rates of tuberculosis in chronic hepatitis C infected patients with or without interferon based therapy: a population-based cohort study in Taiwan.

Authors:  Shang-Yi Lin; Tun-Chieh Chen; Po-Liang Lu; Chun-Yu Lin; Wei-Ru Lin; Yi-Hsin Yang; Yen-Hsu Chen
Journal:  BMC Infect Dis       Date:  2014-12-19       Impact factor: 3.090

Review 4.  Type I Interferons in the Pathogenesis of Tuberculosis: Molecular Drivers and Immunological Consequences.

Authors:  Meg L Donovan; Thomas E Schultz; Taylor J Duke; Antje Blumenthal
Journal:  Front Immunol       Date:  2017-11-27       Impact factor: 7.561

Review 5.  Interactions between Type 1 Interferons and the Th17 Response in Tuberculosis: Lessons Learned from Autoimmune Diseases.

Authors:  Bas C Mourik; Erik Lubberts; Jurriaan E M de Steenwinkel; Tom H M Ottenhoff; Pieter J M Leenen
Journal:  Front Immunol       Date:  2017-04-05       Impact factor: 7.561

Review 6.  Type I interferons in tuberculosis: Foe and occasionally friend.

Authors:  Lúcia Moreira-Teixeira; Katrin Mayer-Barber; Alan Sher; Anne O'Garra
Journal:  J Exp Med       Date:  2018-04-17       Impact factor: 17.579

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.